Life Term Strategies

1. Huge Gains in Long Term
- Receive significant capital gains
- by investing in corporations
- (with wide economic moat & average peers’ net margin)
- In very very long term

2. Strong Periodic Cash Flow
- Maintain self-sufficient monthly cash flow
- Through dividend, gains on derivative & short term trading
- For re-investment to item # 1 mentioned above

3. Mind for Risk Management
- Ensure strong cash position
- Maintain low risk by continue monitor, analyze & feel:
economic trend & environment,
market condition & investors emotion
corporate performance & outlook
asset allocation & direction

4. Be a holy Christian investor:
- Invest in wisdom & varies ways, but consistent & not over nor under of what the Holy Bible expects a Jesus follower should be
- Keep regular & long term spiritual growth
Continue experience God @ finance market
Aim for life transform opportunities
- Even though it may not teach Billy & Bilibala what stocks to invest nor how to make more, more & more $

11.26.2009

FDA grants full approval to J&J's HIV drug

http://www.forbes.com/feeds/ap/2009/11/25/business-health-care-us-j-amp-j-hiv-drug_7159873.html
Associated Press, 11.25.09, 04:03 PM EST

BRIDGEWATER, N.J. --
A division of Johnson & Johnson said Wednesday that federal regulators granted full approval to an HIV drug designed to treat patients who have stopped responding to other treatments.

=> It is good if one can develop an HIV drug

The Food and Drug Administration gave Intelence preliminary approval in January 2008 under its accelerated approval program, which allowed J&J to market the drug. In order to gain full approval, FDA required the company to submit follow-up data on the drug's effectiveness.
More recent data submitted by J&J's Tibotec unit showed that 60 percent of patients taking the drug for 48 weeks had undetectable levels of HIV in their blood compared with 38 percent of patients taking a placebo.

Intelence is a non-nucleoside reverse transcriptase inhibitor, or NNRTI, that blocks the enzyme HIV needs to multiply. The twice-daily tablet is already approved for use in 50 countries around the world.

Tibotec Therapeutics is a division of Ortho Biotech Products LP, a Johnson & Johnson company based in Bridgewater, N.J.

Shares of Johnson & Johnson rose 15 cents to $63.34.
at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)
The information provided in the entire blog is not intended to provide legal, accounting, tax or specific investment advice. The information presented was obtained from sources believed to be reliable; however, I cannot represent that it is accurate or complete. I assume no responsibility for any losses, whether direct, special or consequential, that arise out of the use of this information. This information is subject to change without notice. Stock performance are not guaranteed, their prices change frequently and past performance may not be repeated. Please do your own investigation, or contact your own professional advise, before investing.